Is Becton Dickinson’s Investor Lawsuit Creating A Great Buying Opportunity?
A group of Becton Dickinson (NYSE: BDX) shareholders are suing the healthcare company, claiming it didn't sufficiently disclose certain malfunctions of its Alaris infusion pumps product, thereby exposing the pumps to regulatory issues and delays. In early March, the Food and Drug Administration issued a recall for the Alaris pumps, stating that software issues caused 55 injuries and one death. A law firm representing BD shareholders announced its class action lawsuit shortly thereafter on March 9.
Let's look into what it means for the hospital supplies company and whether there's an attractive buying opportunity for a stock involved in potentially lucrative coronavirus work.
Image source: Getty Images
Source Fool.com
